Clinical Trials in Arizona

Showing 8281-8300 of 16,770 trials

A Study in Subjects With Advanced Solid Tumors

NCT04156100

This study is an open-label, Phase 1 study to evaluate the safety, tolerability, PK, and pharmacodynamic profiles of AGEN1223 as a single-agent and in combination with balstilimab, as well as to assess the maximum tolerated dose and determine the RP2D of AGEN1223 as a single-agent and in combination with balstilimab in subjects with advanced solid tumors.

Advanced Solid Tumor

Agenus Inc.19 participantsStarted Dec 2019

Scottsdale, Arizona, United States • Los Angeles, California, United States • Miami, Florida, United States +1 more locations

WITHDRAWNPhase 131 miles

Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers

NCT04611139

Open-label study of SF-2577 plus pembrolizumab in advanced, recurrent small cell ovarian cancer as well as select additional ovarian and endometrial cancers within the SWI/SNF pathway.

SCCOHTOvarian Clear Cell TumorOvarian Endometrioid Adenocarcinoma+1 more

HonorHealth Research InstituteStarted Dec 2021

Scottsdale, Arizona, United States

TERMINATEDPhase 231 miles

Safety and Efficacy of AMG 827 in Subjects With RA

NCT01059448

This is an extension study for subjects who participated in Protocol 20090061 (NCT00950989). All subjects in this study will receive a 210mg injection of AMG827 for treatment for their Rheumatoid Arthritis for up to 5 years.

Rheumatoid Arthritis

Amgen211 participantsStarted Jun 2010

Scottsdale, Arizona, United States • Tucson, Arizona, United States • La Jolla, California, United States +41 more locations

A Study in Subjects With Advanced Solid Tumors

Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers

Safety and Efficacy of AMG 827 in Subjects With RA

Find Trials by Condition in Arizona

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)

PK Study of Liquid Formulation of BIO89-100 in Subjects With NASH With Compensation Cirrhosis

Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients

A Brief App-based Mobile Health and Well-being Intervention Among Middle-aged Adults

Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)

Mylan Insulin Aspart Study

Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide

Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer

A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults

A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes

Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation

Zilver® PTX® V Clinical Study

Alveolar Bone Changes in Diabetes (ABCD) Study

CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)